Vericel Corporation

US$54.62As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:VCELHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 37.79%
Div yield —
ROE 9.44%
Biotechnology
Beta (5Y) 1.06
PE TTM 88.55
TSR TTM 55.79%
Mkt cap US$2.787B
ROIC 8.68%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$62
12.70%
(72.23%)
Hold 3|0|3|9|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.73
0.70
0.73
0.76
(1.67%)
(13.89%)
(6.26%)
1.67%
Revenue$M
134.1
136.5
141.7
137.7
9.41%
6.37%
5.51%
2.61%
Peers (US$2.787B)
Cap (US$)
PE
2.824B
16.51x
2.683B
—
2.756B
259.4x
Capital
TTM
5Y
10Y
Leveragex
0.598
8.675
6.454
EBIT/Intx
0.284
0.420
0.442
Own earn%
(22.53)
(14.94)
(6.37)
Sh yield%
45.27
21.02
21.10
Owners
Insiders/Inst%
14.11
72.94
Short interest%
5.37
SBC / revenue%
0.70
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
11–23
$1 testx
—
Incr. ROIC%
4